MyoKardia's Series A - II Round

MyoKardia raised a round of funding on August 22, 2014. Investors include Sanofi Sunrise.

MyoKardia is developing a precision medicine approach to treat patients with genetic heart disease. By combining leading-edge cardiovascular genetics with recent advances in heart muscle biochemistry,…

Articles about MyoKardia's Series A - II Round: